Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on April 22, 2008, to announce a significant change in its executive leadership. The report details the appointment of Robin L. Washington as the new Senior Vice President and Chief Financial Officer (CFO), effective May 5, 2008. This appointment marks a transition from Dr. John F. Milligan, who had been serving as interim CFO while continuing his role as Chief Operating Officer. Ms. Washington brings a wealth of financial experience from her previous roles, including CFO at Hyperion Solutions and Senior Vice President and Corporate Controller at PeopleSoft. Her compensation package includes a substantial base salary, bonus potential, a signing bonus, stock options, and restricted stock units, reflecting her importance to the company's strategic financial operations. Investors should note this transition as it signals a new phase in Gilead's financial leadership.
Key Highlights
- 1Robin L. Washington appointed as Senior Vice President and Chief Financial Officer (CFO), effective May 5, 2008.
- 2Dr. John F. Milligan transitions from interim CFO role back to Chief Operating Officer.
- 3Ms. Washington's background includes CFO at Hyperion Solutions and senior finance roles at PeopleSoft.
- 4New CFO's compensation includes a $500,000 annual base salary.
- 5Eligible for a target bonus of 45% of base salary for the 2008 fiscal year.
- 6Receives a $125,000 signing bonus.
- 7Granted stock options for 100,000 shares and 15,000 restricted stock units, with vesting schedules tied to continued employment and performance objectives.